Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense
Open Access
- 1 June 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (6) , 1183-1188
- https://doi.org/10.1128/aac.34.6.1183
Abstract
DL-alpha-Difluoromethylornithine is an enzyme-activated inhibitor of ornithine decarboxylase and an antagonist of polyamine metabolism that has been successful in clinical trials against West African sleeping sickness caused by Trypanosoma brucei gambiense. Its potential for use against the more virulent East African form of the disease, caused by T. brucei rhodesiense, is not certain. We examined 14 East African clinical isolates from the Kenya Trypanosomiasis Research Institute strain bank plus 2 established isolates for susceptibility to DL-alpha-difluoromethylornithine and to standard trypanocides. Seven of 16 strains were partially or totally refractory to DL-alpha-difluoromethylornithine in our test system. Four strains were also refractory to arsenical drugs, and five were refractory to diamidines. The results indicate that other novel agents or combinations of established agents may be needed for chemotherapy of East African disease.This publication has 22 references indexed in Scilit:
- Biochemical changes associated with α-difluoromethylornithine uptake and resistance in Trypanosoma bruceiMolecular and Biochemical Parasitology, 1987
- In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma bruceiMolecular and Biochemical Parasitology, 1987
- A Trypanosoma brucei mutant resistant to α-difluoromethylornithineMolecular and Biochemical Parasitology, 1987
- Necessity of antibody response in the treatment of African trypanosomiasis with α-difluoromethylornithineBiochemical Pharmacology, 1986
- In vivo effects of α-dl-Difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei bruceiMolecular and Biochemical Parasitology, 1983
- Drug sensitivity of pleomorphic Trypanosoma rhodesienseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- Role of Calcium in Trypanocidal Drug ActionScience, 1982
- The brain as a source of relapsing Trypanosoma brucei infection in mice after chemotherapyInternational Journal for Parasitology, 1979
- The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapyParasitology, 1977
- Pentamidine Transport and Sensitivity in brucei‐Group Trypanosomes*The Journal of Protozoology, 1976